TTRX

Turn Therapeutics Inc.

Latest Form 4:Purchase$9KbyChaudhary Zuraiz (See Remarks) · filed Dec 12, 2025

Turn Therapeutics Inc. (TTRX) has 11 SEC Form 4 filings (15 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jun 1, 2026.

The most active filer is See Remarks Chaudhary Zuraiz with 5 filings.

  • Industry:Biotechnology
  • CEO:Bradley E. Burnam
  • Employees:2
  • HQ:Westlake Village, CA, US
  • IPO:2025-10-08

Insider Buying

$275K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

3

in the rolling window

Market Cap

$284.2M

latest known value

Source
Purchase$9KDec 12SEC ↗
Purchase$59KNov 24SEC ↗
Purchase$4KNov 21SEC ↗
Purchase$3KNov 21SEC ↗
Purchase$9KNov 17SEC ↗
Chesed AbrahamFirst filing
Purchase$66KOct 29SEC ↗
Chaudhary ZuraizFirst filing
Purchase$25KOct 23SEC ↗
GOLDEN ARTHUR FFirst filing
Purchase$100KOct 23SEC ↗

Related companies

Turn Therapeutics Inc. is in the Healthcare sector.